NEW YORK (GenomeWeb) – Qiagen said yesterday that it has inked a master collaboration for companion diagnostics codevelopment with Array BioPharma, the 15th pharma agreement of this type.

Qiagen issued a statement highlighting the agreement and marking it as a milestone for its portfolio of master collaboration deals, which span multiple projects.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

ScienceInsider reports that a new security policy at the US Food and Drug Administration may prevent foreign nationals from working there.

WBUR in Boston looks into Orig3n's genetic fitness assessments to find more research is needed.

Cleveland.com reports that getting a DNA profile removed from a law enforcement database can be tricky.

In PNAS this week: de novo mutations contribute to non-syndromic craniosynostosis, fungal tree of life, and more.